CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer
Jin Huang, Pan Chen, Ke Liu, Jiao Liu, Bo Zhou, Runliu Wu, Peng Qiu, Zexian Liu, Changfeng Li, Guido Guido Kroemer, Michael T. Lotze, Herbert J. Zeh, Rui Kang, Daolin Tang (2020). CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer. , 70(5), DOI: https://doi.org/10.1136/gutjnl-2019-320441.
